Annual CFI
-$1.29 M
+$4.80 M+78.84%
December 31, 2024
Summary
- As of March 12, 2025, OCUL annual cash flow from investing activities is -$1.29 million, with the most recent change of +$4.80 million (+78.84%) on December 31, 2024.
- During the last 3 years, OCUL annual CFI has fallen by -$94.00 thousand (-7.87%).
- OCUL annual CFI is now -103.47% below its all-time high of $37.07 million, reached on December 31, 2016.
Performance
OCUL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$202.00 K
-$113.00 K-126.97%
December 31, 2024
Summary
- As of March 12, 2025, OCUL quarterly cash flow from investing activities is -$202.00 thousand, with the most recent change of -$113.00 thousand (-126.97%) on December 31, 2024.
- Over the past year, OCUL quarterly CFI has dropped by -$113.00 thousand (-126.97%).
- OCUL quarterly CFI is now -100.81% below its all-time high of $24.87 million, reached on March 31, 2016.
Performance
OCUL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.29 M
+$257.00 K+16.63%
December 31, 2024
Summary
- As of March 12, 2025, OCUL TTM cash flow from investing activities is -$1.29 million, with the most recent change of +$257.00 thousand (+16.63%) on December 31, 2024.
- Over the past year, OCUL TTM CFI has increased by +$257.00 thousand (+16.63%).
- OCUL TTM CFI is now -102.81% below its all-time high of $45.86 million, reached on September 30, 2016.
Performance
OCUL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OCUL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.8% | -127.0% | +16.6% |
| 3 y3 years | -7.9% | +68.0% | -7.9% |
| 5 y5 years | +42.5% | +66.4% | +42.5% |
OCUL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.9% | +78.8% | -127.0% | +94.0% | -7.9% | +84.5% |
| 5 y | 5-year | -53.1% | +78.8% | -127.0% | +94.0% | -71.7% | +84.5% |
| alltime | all time | -103.5% | +96.7% | -100.8% | +99.5% | -102.8% | +98.3% |
Ocular Therapeutix Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$1.29 M(-78.8%) | -$202.00 K(+127.0%) | -$1.29 M(-16.6%) |
| Sep 2024 | - | -$89.00 K(-88.0%) | -$1.54 M(-9.9%) |
| Jun 2024 | - | -$742.00 K(+191.0%) | -$1.72 M(-42.1%) |
| Mar 2024 | - | -$255.00 K(-44.4%) | -$2.96 M(-51.3%) |
| Dec 2023 | -$6.09 M(+63.8%) | -$459.00 K(+77.2%) | -$6.09 M(-21.7%) |
| Sep 2023 | - | -$259.00 K(-87.0%) | -$7.78 M(-6.4%) |
| Jun 2023 | - | -$1.99 M(-41.1%) | -$8.31 M(+21.9%) |
| Mar 2023 | - | -$3.38 M(+57.2%) | -$6.82 M(+83.5%) |
| Dec 2022 | -$3.71 M(+211.1%) | -$2.15 M(+170.8%) | -$3.71 M(+69.2%) |
| Sep 2022 | - | -$794.00 K(+60.4%) | -$2.20 M(+30.9%) |
| Jun 2022 | - | -$495.00 K(+79.3%) | -$1.68 M(+27.9%) |
| Mar 2022 | - | -$276.00 K(-56.3%) | -$1.31 M(+9.9%) |
| Dec 2021 | -$1.19 M(+42.0%) | -$631.00 K(+128.6%) | -$1.19 M(+46.3%) |
| Sep 2021 | - | -$276.00 K(+114.0%) | -$816.00 K(+8.2%) |
| Jun 2021 | - | -$129.00 K(-18.4%) | -$754.00 K(+0.5%) |
| Mar 2021 | - | -$158.00 K(-37.5%) | -$750.00 K(-10.8%) |
| Dec 2020 | -$841.00 K(-62.4%) | -$253.00 K(+18.2%) | -$841.00 K(-29.3%) |
| Sep 2020 | - | -$214.00 K(+71.2%) | -$1.19 M(-14.7%) |
| Jun 2020 | - | -$125.00 K(-49.8%) | -$1.39 M(-20.9%) |
| Mar 2020 | - | -$249.00 K(-58.6%) | -$1.76 M(-21.3%) |
| Dec 2019 | -$2.24 M(+18.5%) | -$601.00 K(+43.4%) | -$2.24 M(+5.8%) |
| Sep 2019 | - | -$419.00 K(-15.0%) | -$2.12 M(-2.5%) |
| Jun 2019 | - | -$493.00 K(-32.0%) | -$2.17 M(-2.8%) |
| Mar 2019 | - | -$725.00 K(+51.4%) | -$2.23 M(+18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$1.89 M(-107.0%) | -$479.00 K(+1.3%) | -$1.89 M(-4.3%) |
| Sep 2018 | - | -$473.00 K(-14.9%) | -$1.97 M(+271.1%) |
| Jun 2018 | - | -$556.00 K(+45.9%) | -$532.00 K(-102.8%) |
| Mar 2018 | - | -$381.00 K(-32.4%) | $18.73 M(-30.5%) |
| Dec 2017 | $26.95 M(-27.3%) | -$564.00 K(-158.2%) | $26.95 M(+62.0%) |
| Sep 2017 | - | $969.00 K(-94.8%) | $16.64 M(-38.3%) |
| Jun 2017 | - | $18.70 M(+138.4%) | $26.99 M(+34.7%) |
| Mar 2017 | - | $7.85 M(-172.1%) | $20.04 M(-45.9%) |
| Dec 2016 | $37.07 M(-196.1%) | -$10.88 M(-196.1%) | $37.07 M(-19.2%) |
| Sep 2016 | - | $11.32 M(-3.7%) | $45.86 M(+559.2%) |
| Jun 2016 | - | $11.76 M(-52.7%) | $6.96 M(+67.3%) |
| Mar 2016 | - | $24.87 M(-1292.4%) | $4.16 M(-110.8%) |
| Dec 2015 | -$38.57 M(-0.0%) | -$2.09 M(-92.4%) | -$38.57 M(-48.1%) |
| Sep 2015 | - | -$27.59 M(-408.0%) | -$74.25 M(+58.2%) |
| Jun 2015 | - | $8.96 M(-150.2%) | -$46.94 M(-16.4%) |
| Mar 2015 | - | -$17.85 M(-52.7%) | -$56.14 M(+45.5%) |
| Dec 2014 | -$38.59 M(+9870.5%) | -$37.77 M(>+9900.0%) | -$38.59 M(+3664.5%) |
| Sep 2014 | - | -$274.00 K(+10.5%) | -$1.02 M(+19.2%) |
| Jun 2014 | - | -$248.00 K(-16.5%) | -$860.00 K(+29.7%) |
| Mar 2014 | - | -$297.00 K(+44.2%) | -$663.00 K(+71.3%) |
| Dec 2013 | -$387.00 K(-110.1%) | -$206.00 K(+89.0%) | -$387.00 K(+113.8%) |
| Sep 2013 | - | -$109.00 K(+113.7%) | -$181.00 K(+151.4%) |
| Jun 2013 | - | -$51.00 K(+142.9%) | -$72.00 K(+242.9%) |
| Mar 2013 | - | -$21.00 K | -$21.00 K |
| Dec 2012 | $3.81 M | - | - |
FAQ
- What is Ocular Therapeutix annual cash flow from investing activities?
- What is the all time high annual CFI for Ocular Therapeutix?
- What is Ocular Therapeutix annual CFI year-on-year change?
- What is Ocular Therapeutix quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly CFI year-on-year change?
- What is Ocular Therapeutix TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ocular Therapeutix?
- What is Ocular Therapeutix TTM CFI year-on-year change?
What is Ocular Therapeutix annual cash flow from investing activities?
The current annual CFI of OCUL is -$1.29 M
What is the all time high annual CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high annual cash flow from investing activities is $37.07 M
What is Ocular Therapeutix annual CFI year-on-year change?
Over the past year, OCUL annual cash flow from investing activities has changed by +$4.80 M (+78.84%)
What is Ocular Therapeutix quarterly cash flow from investing activities?
The current quarterly CFI of OCUL is -$202.00 K
What is the all time high quarterly CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly cash flow from investing activities is $24.87 M
What is Ocular Therapeutix quarterly CFI year-on-year change?
Over the past year, OCUL quarterly cash flow from investing activities has changed by -$113.00 K (-126.97%)
What is Ocular Therapeutix TTM cash flow from investing activities?
The current TTM CFI of OCUL is -$1.29 M
What is the all time high TTM CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM cash flow from investing activities is $45.86 M
What is Ocular Therapeutix TTM CFI year-on-year change?
Over the past year, OCUL TTM cash flow from investing activities has changed by +$257.00 K (+16.63%)